Aligos Therapeutics, Inc. (ALGS) vs Lisata Therapeutics, Inc. (LSTA)
- Aligos Therapeutics, Inc. ALGS 2.10 +6.06%
- Lisata Therapeutics, Inc. LSTA 1.21 −5.47%
Aligos Therapeutics, Inc. and Lisata Therapeutics, Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and Lisata Therapeutics, Inc. are of similar size ($14.0M and $13.8M). Aligos Therapeutics, Inc. grew revenue faster over the last twelve months: 1,171.6% against −24.7%. Lisata Therapeutics, Inc. has the higher net margin (0.00% vs −197.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Lisata Therapeutics, Inc. leads on 9 and Aligos Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ALGS | LSTA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.49% | 67.24% |
| Operating margin | (215.55%) | 0.00% | 0.00% |
| Net margin | (197.01%) | 0.00% | 0.00% |
| Free cash flow margin | (204.07%) | 0.00% | 0.00% |
| Return on equity | (159.46%) | (101.66%) | (50.28%) |
| Return on assets | (84.46%) | (80.81%) | (45.89%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack